Renaissance Technologies - SORRENTO THERAPEUTICS INC ownership

SORRENTO THERAPEUTICS INC's ticker is SRNE and the CUSIP is 83587F202. A total of 75 filers reported holding SORRENTO THERAPEUTICS INC in Q2 2015. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of SORRENTO THERAPEUTICS INC
ValueSharesWeighting
Q4 2018$1,936,000
+358.8%
806,763
+741.1%
0.00%
Q3 2018$422,000
-94.1%
95,916
-92.3%
0.00%
-100.0%
Q2 2018$7,149,000
+54.7%
1,248,426
+39.2%
0.00%
-20.0%
Q1 2018$4,620,000
+1063.7%
897,163
+284.1%
0.01%
Q3 2017$397,000
+220.2%
233,563
+278.2%
0.00%
Q2 2017$124,000
-57.2%
61,763
+14.6%
0.00%
-100.0%
Q1 2016$290,000
+14.2%
53,890
+84.6%
0.00%0.0%
Q4 2015$254,000
-75.0%
29,190
-49.3%
0.00%
-50.0%
Q2 2015$1,014,00057,5470.00%
Other shareholders
SORRENTO THERAPEUTICS INC shareholders Q2 2015
NameSharesValueWeighting ↓
B. Riley Financial, Inc. 5,216,250$4,621,5981.04%
B. Riley Securities, Inc. 5,216,250$4,621,5981.00%
EMFO, LLC 209,398$185,5270.19%
Wellspring Financial Advisors, LLC 483,551$428,4260.14%
Mayo Clinic 300,000$267,0000.14%
swisspartners Ltd. 110,000$97,4650.12%
Donald L. Hagan, LLC 169,514$150,1890.09%
Oaktree Fund Advisors, LLC 66,000$58,4760.09%
EUDAIMONIA ADVISORS LLC 138,887$123,0540.08%
Asset Management Resources, LLC 138,020$122,2860.08%
View complete list of SORRENTO THERAPEUTICS INC shareholders